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Abstract
Background: Whole-genome bisulfite sequencing currently provides the highest-precision view of the epigenome,
with quantitative information about populations of cells down to single nucleotide resolution. Several studies have
demonstrated the value of this precision: meaningful features that correlate strongly with biological functions can be
found associated with only a few CpG sites. Understanding the role of DNA methylation, and more broadly the role of
DNA accessibility, requires that methylation differences between populations of cells are identified with extreme
precision and in complex experimental designs.
Results: In this work we investigated the use of beta-binomial regression as a general approach for modeling
whole-genome bisulfite data to identify differentially methylated sites and genomic intervals.
Conclusions: The regression-based analysis can handle medium- and large-scale experiments where it becomes
critical to accurately model variation in methylation levels between replicates and account for influence of various
experimental factors like cell types or batch effects.
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Background
DNA methylation is a chemical modification of DNA
resulting from the addition of a methyl group to a DNA
nucleotide. In vertebrates, DNA methylation – which
chiefly occurs at cytosines within CpG dinucleotides –
has been associated with numerous biological functions.
For example, methylation plays a key role in genomic
imprinting, X-chromosome inactivation [1,2], and has
been associated with suppression of transposable ele-
ments during embryonic development [3]. Numerous
studies have shown correlation between promoter methy-
lation and gene expression. Furthermore, the presence of
large-scale abnormally methylated genomic regions is a
hallmark feature of many types of cancers [4].
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Whole-genome bisulfite sequencing (WGBS) is cur-
rently the state-of-the-art technology for obtaining a com-
prehensive, nucleotide-resolution view of the epigenome.
A key step in WGBS is the bisulfite treatment of DNA
designed to convert unmethylated cytosines to uracils
and leave the methylated cytosines unchanged. Dur-
ing sequencing, unmethylated cytosines are read out as
thymines. In this way, the presence of mismatches in
the aligned reads can determine the methylation states
of the cytosines in the DNA molecules that gave rise
to the reads. Typical WGBS experiments involve DNA
molecules originating from many distinct cells and, con-
sequently, the methylation state of a particular cytosine
may differ from one molecule to another. Because of this,
methylation of a single cytosine in the context of WGBS
experiments is described by its methylation level or the
fraction of molecules in the sample where that cytosine
is methylated (see also [5]). Therefore, methylation levels
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can be estimated from the proportions of reads indicating
methylation at each site.
The epigenetic differences between groups of replicate
samples are typically described by individual differen-
tially methylated (DM) sites (e.g. individual cytosines or
CpG dinucleotides) and DM regions – regions domi-
nated by DM sites. Detection of methylation changes
between groups of replicates requires taking into account
variation of methylation levels within each group. Such
variation could be attributed to a variety of technical
and biological sources including different library prepa-
ration protocols, unequal cytosine conversion rates, or
the natural epigenetic variation between individuals [6].
For example, Rakyan and others [7] highlighted some
distributions of methylation levels across replicates that
could arise in the context of epigenome-wide association
studies.
A number of approaches currently exist for assessing
differential methylation from WGBS data. One of the
most straightforward and commonly used methods for
comparing epigenomes of a pair of samples is Fisher’s
Exact Test [8-11]. There are also DM detection algo-
rithms based on hidden Markov models (HMMs). A
recently released tool ComMet, included in the Bisul-
fighter methylation analysis suite [12], is also designed to
detect DM regions and DM sites between two samples.
Another HMM-based DM detection method is included
in the MethPipe methylation analysis pipeline [13,14].
This method first uses HMMs to detect lowly methy-
lated regions, called hypo methylated regions (HMRs)
for each sample and then constructs DM regions from
the fragments of HMRs. Existing methods based on
Fisher’s Exact Test and HMMs are appropriate for com-
paring a pair of samples at a time (coming either
directly from the experiment or obtained by pool-
ing other samples); however, they lack the ability to
account for variability of methylation levels between
replicates.
Another variety of DM detection algorithms are based
on smoothing. These methods operate under the assump-
tion that methylation levels vary smoothly along the
genome. They use local smoothing to estimate the true
methylation level of each site in each sample. For exam-
ple, the DM detection algorithm included in the BSmooth
methylation analysis pipeline [15] is designed to com-
pute DM regions between two groups of samples. After
smoothing, BSmooth performs a statistical test, similar
to the t-test, to find DM sites which form DM regions.
BiSeq [16] is another method based on smoothing. Unlike
BSmooth, it can be used for experiments that go beyond
comparing two groups of samples, but it requires a
set of candidate regions that may exhibit differential
methylation. Thus BiSeq is suitable for the analysis of
data from reduced representation bisulfite sequencing
(RRBS) and other experiments designed to assess methy-
lation of a specific set of genomic intervals. Because
smoothing-based methods perform smoothing on each
sample individually, care must be taken when dealing
with regions where methylation levels are difficult or
impossible to estimate due to very low or no coverage,
and regions where methylation has sharp changes (e.g.
transcription factor binding sites). This said, smoothing-
based methods have been demonstrated to facilitate accu-
rate and reproducible differential methylation analysis
[15].
A few recently released DM-detection methods are
based on the beta-binomial distribution. The beta-
binomial, which has first been used for modeling WGBS
proportions by Molaro and others [17], is a natural choice
for describing methylation levels of an individual site
across replicates as it can account for both sampling
and epigenetic variability. A method implemented in the
bioconductor package DSS [18] constructs a genome-
wide prior distribution for the beta-binomial dispersion
parameter and then uses it to estimate the distribution
of methylation levels in each group of replicates. The dif-
ferentially methylated sites are determined by testing the
means of these distributions for equality. The MOABS
algorithm [19] constructs a genome-wide distribution of
methylation levels and then uses it to estimate the dis-
tribution of methylation levels at individual sites. The
significance of differential methylation is subsequently
determined by an estimate of the methylation difference
between the two groups of replicate samples. The preci-
sion with which these methods determine if a given site is
differentially methylated depends on how closely does the
distribution of site’s methylation levels across replicates
or the dispersion parameter resembles the genome-wide
prior.
Another category of DM detection algorithms are based
on regression. BiSeq, mentioned earlier, performs a beta
regression after smoothing and so also fits into this cate-
gory. MethylKit [20] uses logistic regression to test for dif-
ferential methylation at individual sites; its model assumes
that the number of reads indicating methylation follows a
binomial distribution across replicates.
The existing methods for detecting differential methy-
lation lack either the ability to analyze WGBS datasets
in complex experimental designs or the ability to
account for variation across biological replicates. These
limitations reduce the usefulness of current methods
for analysis of multifactor WGBS datasets that are
emerging in the contexts of epigenome-wide associa-
tion studies (EWAS) and other studies aiming to answer
questions about groups and populations of individu-
als. Here we introduce a novel DM-detection method
based on beta-binomial regression that overcomes these
limitations.
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Methods
We start by discussing the utility of the beta-binomial
regression for modeling methylation levels of individual
sites (e.g. C, CpGs, CHH, CHG) across multiple sam-
ples. This approach is especially useful in the context of
epigenome-wide association studies (EWAS) that typically
involve methylomes of many individuals and, potentially,
numerous sites with complicated methylation profiles
across the replicates.
As mentioned in the introduction, the methylation
level of an individual site is the fraction of molecules in
the sample that have a methyl group at that site. This
level can be computed separately for each strand, but
we will assume throughout that the methylation level
refers to both strands. Assume that n reads from the
WGBS experiment map over a given cytosine, and that
the cytosine is methylated in m of these reads. Then
(m, n) is the read proportion corresponding to the site.
In the absence of any biological or technical variation,
m ∼ binom(p, n), where p is the unknown methyla-
tion level of the site. So the unbiased estimator for p is
pˆ = m/n.
However, it is widely recognized that variation exists
and arises from multiple biological and technical sources
[7,15]. Thus, when dealing with multiple replicates, we
must associate some uncertainty with each methylation
level. Let pi denote the methylation level of the site in
the ith replicate. (This way, pis give the methylation level
of the cytosine under consideration across all available
replicates). The typical assumption is pi ∼ Beta(α,β)
for some shape parameters α ≥ 0 and β ≥ 0. Using
the beta distribution in such analysis, however, requires
that we know the values of pi as the basis for infer-
ences about the α and β . If we use pˆis directly, we are
ignoring any uncertainty in their estimates. While this is
appropriate for studies based on BeadArray technology
[21], which estimate each pi based on interrogating very
large numbers of molecules, there are many important
and emerging contexts in which sequencing-based studies
will involve low values of ni (coverage of the cytosine in
sample i).
The coverage issue discussed in the previous paragraph
can be addressed by using the beta-binomial distribu-
tion instead of the beta. The beta-binomial distribution
retains the flexibility of beta in modeling the distribution
of methylation levels across replicates and, at the same
time, takes into account the uncertainty associated with
coverage.
Beta-binomial distribution
The beta-binomial is a compound distribution obtained
from the binomial by assuming that its probability
of success parameter follows a beta distribution.
The beta-binomial is obtained from Binom(p, n) by
assuming p ∼ Beta(α,β) resulting in the probability mass
function
Pr(M = m|n,α,β) =
(n
m
)B(m + α, n − m + β)
B(α,β) , (1)
where B is the beta function. Reparametrization π :=
α/(α + β) and γ := 1/(α + β + 1) yields
E(M) = nπ and Var(M) = nπ(1 − π)(1 + (n − 1)γ ).
The parameter π is the analog of the binomial proba-
bility of success parameter which can be interpreted as
the average methylation level of a set of replicate sam-
ples. The parameter γ is called the dispersion parameter.
Observe that the binomial distribution is a special case of
beta-binomial distribution with γ equal to 0.
Beta-binomial regression
We use beta-binomial regression [22] to individually
model the methylation levels of every site across the given
set of samples. Let M1, . . . ,Ms be the i.i.d random vari-
ables corresponding to the number of reads indicating
methylation of the site in the samples 1, . . . , s so that
Mi ∼ BetaBinomial (ni,πi, γ ) .




, where g is a
link function, X is an s × t model matrix, and η is a
t × 1 vector of regression parameters. Finally, γ is a com-
mon dispersion parameter. The columns of the model
matrix correspond to the binary experimental factors (e.g.
membership to the control group) or individual levels
of multi-level factors (e.g. one of, say, three possible cell
types).









, so that an increase of the regres-
sion parameter ηj by b units can be interpreted as the log
odds ratio b = log ((π ′i/ (1 − π ′i )) / (πi/ (1 − πi))), where
πi is the mean methylation level corresponding to the
parameter vector η and π ′ is its value when ηj is increased
by b units.
Fitting
The beta-binomial regression is fit separately for each
target site. Given the model matrix X and the read pro-
portions (m1, n1), . . . , (ms, ns), indicating the methylation
status of the target site across s samples, the values of the
regression parameter vector η and distribution parame-
ters γ , πis are estimated using the method of maximum
likelihood. To determine if a site is differentially methy-
lated with respect to the test factor, we fit two regression
models: the full model and the reduced model without the
test factor. The significance of differential methylation is
determined by comparing the full and the reduced models
using the log-likelihood ratio test.
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The p-values for the individual sites from the log-
likelihood ratio test are combined together to increase the
power to detect differential methylation. This approach
enables the detection of differential methylation even in
loci that have low coverage in all samples.
Combining evidence for differential methylation
The p-values are transformed using weighted Z test (also
known as Stouffer-Liptak test), employing an approach
proposed by Kechris and others [23]. Briefly, the idea is to
use Z test to combine the p-value associated with the tar-
get site with the p-values of its neighbors. A sequence of
p-values p1, . . . , pn corresponding to proximal sites is first
transformed to a sequence of Z-scores zi = −1(1 − pi),
for i = 1, . . . , n and then combined using





n +∑i<j cor (zi, zj)
⎞
⎟⎠
as described, for instance, by Zaykin [24]. The correlation
coefficients are calculated as previously described [25].
(The appropriate value of the parameter defining the
width of the window in which to calculate the correlation
between the p-values and subsequently combine them is
discussed in the Additional file 1).
Implementation
The DM detection method described above is imple-
mented in RADMeth: Regression Analysis of Dif-
ferential Methylation software available at http://
smithlabresearch.org. The website contains the
source code released under GNU GPL open-source




To compare performance of DM detection methods we
simulated a dataset containing 12 samples (6 cases and
6 controls). Each sample consisted of CpG read propor-
tions with coverages taken from a recent study of the
mouse brain [26]. The number of reads indicating methy-
lation of each CpG in each sample were taken from the
binomial distribution. The distributions of the probabil-
ity of success parameter (i.e. methylation level) of the
binomials were taken from the work of Rakyan and oth-
ers [7]: The non-differentially methylated CpGs in all
samples had intermediate methylation levels taken from
Beta(2, 2), while differentially methylated CpGs in con-
trol and case samples had low methylation levels from
Beta(1.5, 6) and high methylation levels from Beta(6, 1.5)
respectively.
To get a sense for changes in false positive rates caused
by variation in dispersion, we constructed two additional
datasets. One of the datasets was obtained from the orig-
inal by changing the distribution of non-differentially
methylated CpGs to Beta(1.5, 1.5), corresponding to the
increase in variance from 1/20 to 1/16. The second dataset
had no dispersion in the methylation levels of non-
differentially methylated CpGs: all of them were set to
0.7. Each dataset contained 54,449 DM CpGs lying in
1,000 randomly selected regions that were required to
have between 10 and 100 CpGs with no more than 200 bp
between each pair of neighbors.
We evaluated the performance of eachmethod by calcu-
lating the Jaccard index between the set of CpGs identified
by the method as differentially methylated (which we
denote by M) and the set of truly differentially methy-
lated CpGs (denoted by T). The Jaccard index is given
by |M ∩ T |/|T ∪ M|, i.e. the number of truly differen-
tiallymethylated CpGs identified by a DMmethod divided
by the total number of CpGs that are either truly dif-
ferentially methylated or falsely identified as such. This
way, the perfect method gives the Jaccard index of 1 and
the worst possible method that misidentifies each dif-
ferentially methylated CpG results in the Jaccard index
of 0.
This is howwe applied other existingmethods
We recognize that the compared methods were each opti-
mized for different contexts, and so our results do not
in any way reflect their general value and validity. In
running these other methods, we adjusted parameters
so that each method would perform better on our tests,
which could be significantly different from their intended
contexts.
BSmooth is designed for estimating DM regions, so we
identified all CpGs lying within DM regions as differen-
tially methylated. To compute DM regions with BSmooth,
we filtered out CpGs having coverage below 3 in more
than 3 case samples or 3 control samples and used 4.5 t-
statistics cutoff. Furthermore, we removed all DM regions
with mean methylation difference below 0.1 and contain-
ing fewer than 3 CpGs.
Bisulfighter’s ComMet can be used to compare a pair of
samples. So, to use it on our dataset we pooled read pro-
portions from all case and all control samples. To decrease
the rate of false positives, we discarded all CpGs with
methylation difference below 0.6 between the pooled case
sample and the pooled control sample.
When performing the analysis with DSS and MethylKit,
we defined differentially methylated CpGs as those with
q-value below 0.01. DSS had a low rate of false positives,
but seemed to lack power to identify many differentially
methylated CpGs. The false positive rate of MethylKit
increased with variance. When usingMOABS, we defined
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differentially methylated CpGs as those with credible
methylation difference of 0.2 or above.
With RADMeth, CpGs with FDR corrected p-values
below 0.01 were identified as differentially methylated.
The correlation parameter was set to compute correlation
between p-values of CpGs up to 200 bp from one another.
The Jaccard indexes corresponding to each method
applied to each dataset are described in Figure 1.
The DM detection method included in MethPipe
methylation analysis pipleline is designed for detection of
differential methylation within hypo-methylated regions
and so is a less general DM detection method than
the rest. To better highlight the differences between
this method and ours, we made comparisons using
an additional collection of datasets (see Additional
file 1).
To check howwell RADMeth performs on low-coverage
data, we simulated another dataset consisting of 50 case
and 50 control samples with the average coverage of
1.5 using same distributions of methylation levels as
before (Beta(6, 1.5) for cases, Beta(1.5, 6) for controls, and
Beta(2, 2) for non-differentially methylated CpGs. The
Jaccard index between the set of differentially methy-
lated CpGs identified by RADMeth and true differentially
methylated CpGs was 0.92.
Applying RADMeth to real data
Our method was designed for large, multifactor WGBS
datasets. It is inevitable that such datasets will be avail-
able in the public domain in the very near future, as
on-going EWAS are completed. Analysis of these datasets
requires accounting for (a) variation of methylation lev-
els across replicates, (b) uncertainty associated with
coverage, and also (c) adjustment for baseline differ-
ences due to population structure (e.g. age and sex of
the involved individuals) or batch effects. Unfortunately,
such datasets are largely absent from the public domain.
Nevertheless, we chose two datasets – one multifactor
and one involving a large number of samples – to illus-
trate our DM detection method. (See Additional file 1
for the description of parameters used to analyze each
dataset).
Amultifactor dataset
We compared CpG methylation between neuron and
non-neuron samples from mouse frontal cortex pub-
lished in a recent study of methylation in the mammalian
brain [26]. The 6 MethylC-Seq read libraries were pro-
cessed with MethPipe [14] methylation analysis pipeline
using standard parameter cutoffs. The resulting methy-
lome samples had the mean coverage of 12.4 (s.d. 4.7).
We computed DM CpGs and DM regions between neu-
ron and non-neuron samples adjusting for baseline dif-
ferences related to age and sex (12 month and 6 week
old females, and 7 week old male). Top-left panel of
Figure 2 contains a browser plot [27] with annotated DM
regions and hypo methylated regions (HMRs) within a
promoter of neuron specific enolase (Eno2), a well known
marker of neuron cells [28,29]. The methylation profile of
this gene across the frontal cortex samples reveals elon-
gated HMRs upstream and downstream of the unmethy-
lated promoter core in neuron samples compared to the
ones in non-neuron samples, which constitute the DM
regions.
Overall, there were about 72K DM regions contain-




































































































Figure 1 Comparison of DM detection methods. The Jaccard indexes comparing the truly differentially methylated CpGs to the CpGs identified
as differentially methylated by each method. The panels are labeled according to the distributions of methylation levels of non-differntially
methylated CpGs.





































Figure 2 DM regions between neuron and non-neuron samples. (Top left) Methylation profile of the neuron specific enolase (Eno2) – a marker
of neuron cells – across frontal cortex samples. (Right) Histogram of log-odds-ratios of DM regions containing at least 10 CpGs. (Bottom left)
Histogram of minimummethylation differences of DM regions containing at least 10 CpGs.
file 1). Although predominantly glial, non-neuron sam-
ples consisted of multiple cell types. Hence the majority
of DM regions, especially the ones corresponding to mod-
est methylation changes, are likely to indicate difference
between individual cell types and neurons. To obtain
DM regions with consistent methylation changes between
neurons and non-neurons in the majority of molecules
comprising the samples, we selected DM regions with
minimum methylation difference above 0.55. The 1,708
of these regions were lowly methylated in neurons and
were associated with 1,089 genes. The GO term enrich-
ment analysis, performed using DAVID [30], revealed a
strong association of these genes with various aspects
of neuronal development and function (see Additional
file 2).
Large-scale dataset
The second dataset [31] consisted of 152 MethylC-
seq libraries. The methylome samples obtained from
these libraries with MethPipe [14] had mean coverage
11.2 (s.d. 2.7); 54 of these samples came from inflores-
cence (flower cluster) and the remaining 98 from the
leaf of Aradidopsis thaliana. RADMeth identified 13,576
DM regions between the two groups of samples (see
Additional file 1). Out of these, 5,049 DM regions contain-
ing at least 10 CpG sites were retained for downstream
analysis.
It is well known that methylation in Aradidopsis plays
an important role in silencing of transposable elements
(e.g. [32]), which are usually heavily methylated. Inter-
estingly, most of the DM regions we found overlapped
transposons (1.781 observed over expected ratio; see also
Figure 3). The methylation differences between inflo-
rescence and leaf samples were modest: above 0.1 for
1,271 DM regions and above 0.2 for just 129 regions,
indicating relative loss of methylation within transposons
in a relatively small fraction of sequenced molecules.
Promoter and gene bound DM regions were underrepre-
sented, with 0.19 and 0.28 observed over expected ratios
respectively.




























Figure 3 Classification of Arabidopsis DM regions. A summary of functional classification of 5,049 DM regions containing 10 CpG or more
between 54 inflorescence and 98 leaf samples of Arabidopsis thaliana.
Conclusions
In this work, we discussed the utility of the beta-binomial
regression for comparing the distribution of read propor-
tions corresponding to a single site (a single CpG site)
across a set of WGBS samples under a given experimen-
tal design and then statistically combining the results
of individual comparisons to estimate the DM status of
individual sites and genomic regions.
Beta-binomial regression can model WGBS propor-
tions in groups of samples corresponding to multiple
experimental factors, including case-control experimen-
tal designs or more complicated designs involving, say,
baseline adjustments for multiple cell types. In fact, sim-
ulations based on realistic distributions of methylation
levels (see Additional file 1) show that, compared to the
beta-binomial, the beta regression suffers loss of precision
even at moderate coverage, while the extra-binomial vari-
ation increases the rate of false positives in the binomial
regression. This suggests that beta-binomial regression is
the appropriate way to analyze WGBS data in multifactor
experiments.
The power to detect methylation changes of a given
magnitude (e.g. log-odds ratio) varies with coverage.
Because the coverage at the genome-wide scale is typi-
cally very uneven, it is possible to detect small methylation
changes in regions with high coverage and only much
larger methlation changes when the coverage is low. Com-
bining the p-values associated with proximal cytosines
boosts the significance of sites residing within DM regions
making the detection of even lowly covered regions possi-
ble. There are other methods besides the Z test for com-
bining the p-values, with Fisher’s method being the most
well known. As explained by Rice [33], Fisher’s method is
best suited for testing the existence of at least one signifi-
cant test among the ones being combined, while the Z test
is more appropriate in situations requiring the consensus
among all of the combined tests, suggesting that the Z test
is more appropriate for our purposes.
We note that, in agreement with earlier work [15],
when dealing with the experiments involving small num-
ber of samples, there maybe little choice but to increase
the power to detect differential methylation by leverag-
ing methylation status of multiple sites either locally, as
it is done by smoothing- and HMM-based methods or
genome-wide, as done by some methods based on beta-
binomial distribution.
In summary, the DM detection method described in
this work is capable of (1) accurately modeling the uncer-
tainty associated with coverage, (2) account for the extra-
binomial variation that can arise from multiple biological
and technical sources, (3) detect DM sites and regions
even in loci having low coverage across all available sam-
ples, and (4) do all this while adjusting for the baseline
differences corresponding to the relevant experimental
factors.
Additional files
Additional file 1: Comparison of beta, beta-binomial, and binomial
regressions.
Additional file 2: GO term enrichment of genes associated with DM
regions lowly methylated in neuron samples (performed using
DAVID [30]).
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